Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Percutaneous Coronary Intervention Stenting

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07485491Not ApplicableRecruitingPrimary

Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational Calls

NCT04864119CompletedPrimary

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

NCT04043091Not ApplicableWithdrawnPrimary

Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction

Showing all 3 trials

Research Network

Common Treatments

  • Percutaneous Coronary Intervention Stenting1
  • Clinicianlevel Intervention1
  • Patientlevel Intervention1

Active Sponsors

  • Massachusetts General Hospital2
  • University Medical Centre Ljubljana1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • HeartFlow, Inc.1

Top Investigators

Related Conditions

  • Critical Illness1
  • Percutaneous Coronary Intervention1
  • Coronary Artery Disease1

Activity Timeline